Webinar Series 7 Episode 1

To enhance and modernize the drug development process, many organizations are adopting Organ-on-a-chip (OOC) technologies into their workflows, from efficacy to safety assessment. With evolving developments in the technology and its applications, questions and opportunities are arising, especially with regards to the regulatory landscape for NAMs, cost efficiency, and model confidence through standardization.

In this Learning Lab, originally presented in partnership with GEN, Lab, Dr. Tomasz Kostrzewski, our CSO, and toxicology consultant, Dr. Clive Roper, discuss all things OOC, including current applications, the evolving perspective of regulators, and ongoing efforts to harness the potential of OOC across multiple applications.
Key questions addressed during the webinar include:

• How OOC is transforming drug discovery with its predictive and cost-effective approach.
• Discover how OOC tackles rising costs and prepares for the complexities of new drug modalities.
• Reduction and refinement of animal use while maintaining scientific rigor.
• Current industry challenges and how OOC providers are working to overcome them.
• Regulatory acceptance status, including the regulator’s viewpoint on OOC and ongoing efforts to support increased use.